WO2013109213A3 - Pharmaceutical formulations comprising tiotropium - Google Patents
Pharmaceutical formulations comprising tiotropium Download PDFInfo
- Publication number
- WO2013109213A3 WO2013109213A3 PCT/TR2013/000025 TR2013000025W WO2013109213A3 WO 2013109213 A3 WO2013109213 A3 WO 2013109213A3 TR 2013000025 W TR2013000025 W TR 2013000025W WO 2013109213 A3 WO2013109213 A3 WO 2013109213A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tiotropium
- pharmaceutical formulations
- order
- dry powder
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The present invention relates to pharmaceutical formulations in dry powder comprising tiotropium in order to be used in respiratory tract diseases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201200492 | 2012-01-16 | ||
TR2012/00492 | 2012-01-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013109213A2 WO2013109213A2 (en) | 2013-07-25 |
WO2013109213A3 true WO2013109213A3 (en) | 2013-09-06 |
Family
ID=48237229
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2013/000025 WO2013109213A2 (en) | 2012-01-16 | 2013-01-16 | Pharmaceutical formulations comprising tiotropium |
PCT/TR2013/000028 WO2013109216A2 (en) | 2012-01-16 | 2013-01-16 | Preparation of dry powder formulations comprising tiotropium |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2013/000028 WO2013109216A2 (en) | 2012-01-16 | 2013-01-16 | Preparation of dry powder formulations comprising tiotropium |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2804591A2 (en) |
WO (2) | WO2013109213A2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040136919A1 (en) * | 2002-11-28 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation |
EP2172190A1 (en) * | 2008-10-02 | 2010-04-07 | Laboratorios Liconsa, S.A. | Inhalable particles comprising tiotropium |
WO2011093819A2 (en) * | 2010-01-28 | 2011-08-04 | Mahmut Bilgic | New combination comprising tiotropium |
WO2011093820A2 (en) * | 2010-01-28 | 2011-08-04 | Mahmut Bilgic | A pharmaceutical combination comprising tiotropium |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3931041C2 (en) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them |
WO2011152804A2 (en) * | 2010-06-03 | 2011-12-08 | Mahmut Bilgic | Process for dry powder formulations |
-
2013
- 2013-01-16 WO PCT/TR2013/000025 patent/WO2013109213A2/en active Application Filing
- 2013-01-16 WO PCT/TR2013/000028 patent/WO2013109216A2/en active Application Filing
- 2013-01-16 EP EP13738848.4A patent/EP2804591A2/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040136919A1 (en) * | 2002-11-28 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation |
EP2172190A1 (en) * | 2008-10-02 | 2010-04-07 | Laboratorios Liconsa, S.A. | Inhalable particles comprising tiotropium |
WO2011093819A2 (en) * | 2010-01-28 | 2011-08-04 | Mahmut Bilgic | New combination comprising tiotropium |
WO2011093820A2 (en) * | 2010-01-28 | 2011-08-04 | Mahmut Bilgic | A pharmaceutical combination comprising tiotropium |
Also Published As
Publication number | Publication date |
---|---|
WO2013109213A2 (en) | 2013-07-25 |
EP2804591A2 (en) | 2014-11-26 |
WO2013109216A2 (en) | 2013-07-25 |
WO2013109216A3 (en) | 2014-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1255336A1 (en) | Pharmaceutical formulations and processes of preparation thereof | |
ZA201703992B (en) | Inhalable pharmaceutical compositions | |
HK1205690A1 (en) | Pharmaceutical composition and administration thereof | |
HK1204989A1 (en) | Inhalable dry powders | |
IL222268A (en) | Substituted pyrrolo-pyridines, pharmaceutical compositions comprising them, combined compositions comprising them and their use in the manufacture of medicaments | |
HK1208801A1 (en) | Orally administered medical composition | |
IL235020A0 (en) | N-phenyl benzenesulfonamide derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
EP2906202A4 (en) | Oral drug delivery formulations | |
IL237839A0 (en) | Hydropyrrolopyrrole derivatives, their preparation and pharmaceutical compositions containing them | |
HK1203812A1 (en) | Novel pharmaceutical formulations | |
IL235414A (en) | Pyrrolotriazinone derivatives, their preparation and pharmaceutical compositions containing them | |
IL236057B (en) | 1,2,4-triazine-6-carboxamide derivatives and pharmaceutical compositions comprising them | |
HK1215388A1 (en) | Inhalable pharmaceutical compositions and the inhaler devices containing them | |
HK1211021A1 (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions 2--6--9--9h- | |
IL233825A (en) | 1h-indazole-3-carboxamide compounds, compositions comprising them and uses thereof in the preparation of medicaments | |
EP3020417A4 (en) | Pharmaceutical composition for respiratory administration | |
HK1215167A1 (en) | Inhalable pharmaceutical compositions and the inhaler devices containing them | |
HK1204289A1 (en) | Topical ophthalmological pharmaceutical composition containing cediranib | |
EP2933290A4 (en) | Composition for forming complex, complex formed therefrom, and composition for oral administration including said complex | |
EP2866792A4 (en) | Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture | |
EP2868319A4 (en) | Aripiprazole oral pharmaceutical preparation | |
IL238826A (en) | Imidazol-piperidinyl derivatives, their preparation and pharmaceutical compositions containing them | |
EP2926811A4 (en) | Artemether-containing pharmaceutical composition, preparation, and use thereof | |
WO2013109213A3 (en) | Pharmaceutical formulations comprising tiotropium | |
HK1209339A1 (en) | Pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13720137 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13720137 Country of ref document: EP Kind code of ref document: A2 |